HIV antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cellsMartine Auclair, Jacqueline Capeau|PLoS ONE|2020Cited by 39